Management of vasospastic disorders with botulinum toxin A

Plastic and Reconstructive Surgery

Volumn 119, Issue 1, 2007, Pages 217-226

  Van Beek, Allen L ^a   Lim, Paul K ^a   Gear, Andrew J L ^a   Pritzker, Marc R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; DEBRIDEMENT; DISEASE SEVERITY; FEMALE; FINGER BLOOD FLOW; FOLLOW UP; HAND DISEASE; HUMAN; INFARCTION; INTRACTABLE PAIN; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; SKIN COLOR; SKIN GRAFT; SKIN TEMPERATURE; TIME; TREATMENT OUTCOME; ULCER; ULCER HEALING; VASOSPASM; FINGER; MIDDLE AGED; MUSCLE SPASM; RAYNAUD PHENOMENON; TOE; VASCULAR DISEASE; VASCULARIZATION;

ADULT; AGED; BOTULINUM TOXIN TYPE A; FEMALE; FINGERS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; RAYNAUD DISEASE; SPASM; TOES; VASCULAR DISEASES;

EID: 33847017781     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000244860.00674.57     Document Type: Article

References (26)

1. Koman, L. A. R. D., Smith, B. P., and Smith, T. L. Vascular disorders. In D. P. Green, R. N. Hotchkiss, and W. C. Pederson (Eds.), Green's Operative Hand Surgery. New York: Churchill Livingstone, 1999. Pp. 2254-2302.
2. Uroskie, J., Schmidt, C. C., and Baratz, M. F. Vascular disorders of the hand and upper extremity. In P. Beredjiklian and D. J. Bozentka (Eds.), Review of Hand Surgery. Philadelphia: Saunders, 2004. Pp. 63-78.
3. Wigley, R. D. The Primary Prevention of Rheumatic Diseases. Pearl River, N.Y.: Parthenon, 1994.
4. Wigley, F. M., Wise, R. A., Seibold, J. R., et al. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study. Ann. Intern. Med. 120: 199, 1994.
5. Flatt, A. E. Digital artery sympathectomy. J. Hand Surg. (Am.) 5: 550, 1980.
6. Raynaud, M., and Barlow, T. New Research on the Nature and Treatment of Local Asphyxia of the Extremities. London: New Syndenham Society, 1888.
7. Lewis, T. Experiments relating to the peripheral mechanism involved in spasmodic arrest of circulation in fingers: A variety of Raynaud's disease. Heart 15: 7, 1929.
8. Flavahan, N. A., Flavahan, S., Mitra, S, et al. The vasculopathy of Raynaud's phenomenon and scleroderma. Rheum. Dis. Clin. North Am. 29: 275, 2003.
9. Flavahan, N. A., and Vanhoutte, P. M. Effect of cooling on alpha-1 and alpha-2 adrenergic responses in canine saphenous and femoral veins. J. Pharmacol. Exp. Ther. 238: 139, 1986.
10. Freedman, R. R., Girgis, R., and Mayes, M. D. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma. J. Rheumatol. 26: 2386, 1999.
11. Flavahan, N. A., Flavahan, S., Liu, Q., et al. Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma. Arthritis Rheum. 43: 1886, 2000.
12. Herron, G. S., and Romero, L. I. Vascular abnormalities in scleroderma. Semin. Cutan. Med. Surg. 17: 12, 1998.
13. Herrick, A. L. Vascular function in systemic sclerosis. Curr. Opin. Rheumatol. 12: 527, 2000.
14. Jones, N. F. Acute and chronic ischemia of the hand: Pathophysiology, treatment, and prognosis. J. Hand Surg. (Am.) 16: 1074, 1991.
15. Wilgis, E. F. Digital sympathectomy for vascular insufficiency. Hand Clin. 1: 361, 1985.
16. Koman, L. A., Smith, B. P., Pollock, F. E, Jr., et al. The microcirculatory effects of peripheral sympathectomy. J. Hand Surg. (Am.) 20: 709, 1995.
17. McCall, T. E., Petersen, D. P., and Wong, L. B. The use of digital artery sympathectomy as a salvage procedure for severe ischemia of Raynaud's disease and phenomenon. J. Hand Surg. (Am.) 24: 173, 1999.
18. Ward, W. A., and Van Moore, A. Management of finger ulcers in scleroderma. J. Hand Surg. (Am.) 20: 868, 1995.
19. Yee, A. M., Hotchkiss, R. N., and Paget, S. A. Adventitial stripping: A digit saving procedure in refractory Raynaud's phenomenon. J. Rheumatol. 25: 269, 1998.
20. Sycha, T., Graninger, E., Auff, E., and Schnider, P. Botulinum toxin in the treatment of Raynaud's phenomenon: A pilot study. Eur. J. Clin. Invest. 34: 312, 2004.
21. Rohrich, R. J., Janis, J. E., Fagien, S., et al. The cosmetic use of botulinum toxin. Plast. Reconstr. Surg. 112: 177S, 2003.
22. Benedetto, A. The cosmetic uses of botulinum toxin type A. Int. J. Dermatol. 38: 641, 1999.
23. Atkins, J., and Butler, P. E. M. Hyperhidrosis: A review of current management. Plast. Reconstr. Surg. 110: 222, 2002.
24. Morris, J. L., Jobling, P., and Gibbins, I. L. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am. J. Physiol. 281: H2124, 2001.
25. Jinsi-Parimoo, A., and Deth, R. C. Reconstitution of alpha2Dadrenergic receptor coupling to phospholipase D in a PC12 cell lysate. J. Biol. Chem. 272: 14556, 1997.
26. Bailey, S. R., Eid, A. H., Mitra, S., et al. Rho kinase mediates cold-induced constriction of cutaneous arteries: Role of alpha2C-adrenoceptor translocation. Circ. Res. 94: 1367, 2004.